Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases

BACKGROUND AND IMPORTANCE: Recurrent malignant gliomas (RMGs) are very difficult to control, and no standard treatments have been established for them. We performed boron neutron capture therapy (BNCT) for patients with RMG. BNCT enables high-dose particle radiation to be applied selectively to tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyatake, Shin-Ichi, Kawabata, Shinji, Hiramatsu, Ryo, Furuse, Motomasa, Kuroiwa, Toshihiko, Suzuki, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923505/
https://www.ncbi.nlm.nih.gov/pubmed/24387301
http://dx.doi.org/10.1186/1748-717X-9-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923505/
https://www.ncbi.nlm.nih.gov/pubmed/24387301
http://dx.doi.org/10.1186/1748-717X-9-6

Ejemplares similares